ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM

Feng, Songshan; Liang, Xisong; Li, Jing; Wang, Zeyu; Zhang, Hao; Dai, Ziyu; Luo, Peng; Liu, Zaoqu; Zhang, Jian; Xiao, Xiaoxiong*; Cheng, Quan*南方医科大学; 郑州大学; 1
Frontiers in Immunology2022-9-26DOI: 10.3389/fimmu.2022.992855
4被引8阅读
引用收藏
分享

摘要

Immunogenic cell death (ICD) is a type of cell death that leads to the regulation and activation of the immune response, which is marked by the exposure and delivery of damage-associated molecular patterns (DAMPs) in the tumor microenvironment. Accumulating evidence has revealed the significance of ICD-related genes in tumor progression and therapeutic response. In this study, we obtained two ICD-related clusters for glioblastoma (GBM) by applying consensus clustering, and further constructed a risk signature on account of the prognostic ICD genes. Based on the risk signature, we found that higher risk scores were associated with worse patient prognosis. Besides, the results illustrated that ferroptosis regulators/markers were highly enriched the high-risk group, and ferroptosis were correlated with cytokine signaling pathway and other immune-related pathways. We also discovered that high-risk scores were correlated to specific immune infiltration patterns and good response to immune checkpoint blockade (ICB) treatment. In conclusion, our study highlights the significance of ICD-related genes as prognostic biomarkers and immune response indicators in GBM. And the risk signature integrating prognostic genes possessed significant potential value to predict the prognosis of patients and the efficacy of ICB treatment.

学科与关键词

关键词
immunogenic cell deathrisk modelferroptosisprognosisimmunotherapyglioblastoma
相关
加载中…
  • Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
    Dong, Jiawei; Zhao, Hongtao; Wang, Fang; Jin, Jiaqi; Ji, Hang; Yan, Xiuwei; Wang, Nan; Zhang, Jiheng; Hu, Shaoshan*Frontiers in Neurology, 2022, 13: 829926.被引 6
  • Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
    Li, Yanling; Feng, Jianyuan; Wang, Ting; Li, Mingcui; Zhang, Hanyu; Rong, Zhiyuan; Cheng, Weilun; Duan, Yunqiang; Chen, Ziang; Hu, Anbang; Yu, Tianshui; Zhang, Jiarui; Shang, Yuhang; Zou, Yiyun; Ma, Fei*; Guo, Baoliang*Frontiers in Genetics, 2022, 13: 1069921.被引 4
  • A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
    Peng, Xiaojiang; Liu, Chun; Li, Jing; Bao, Zeqing; Huang, Tao; Zeng, Lingfeng; He, Qixiong; Xue, Daojin*Frontiers in Oncology, 2023, 13: 1128278.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-09-26
卷期
第 13 卷
页码
992855
DOI
10.3389/fimmu.2022.992855
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Hunan Provincial Natural Science Foundation of China; Hunan Provincial Health Committee Foundation of China; Natural Science Foundation General Program of Changsha City; Xiangya Hospital Central South University postdoctoral foundation; [82102848]; [82073893]; [81703622]; [2020JJ8111]; [2022JJ20095]; [2022JJ40830]; [202204044869]; [kq2014290]

作者

  • F

    Feng, Songshan (第一作者)

  • L

    Liang, Xisong

查看全部 11 位作者收起作者
  • L

    Li, Jing

    2

  • W

    Wang, Zeyu

  • Z

    Zhang, Hao

  • D

    Dai, Ziyu

  • L

    Luo, Peng

    southern med univ

  • L

    Liu, Zaoqu

    1 · zhengzhou univ

  • Z

    Zhang, Jian

    southern med univ

  • X

    Xiao, Xiaoxiong (通讯)

  • C

    Cheng, Quan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417